For €50 a month, some people are buying into cryogenic preservation, hoping the future holds the key to immortality. With investors pouring millions into Tomorrow Biostasis, the once-fantastical idea is edging into the mainstream. But critics warn that what’s being sold isn’t science — it’s hope on ice.
